Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females

Prostaglandins and Other Lipid Mediators

Volumn 123, Issue , 2016, Pages 68-77

  Peterson, Stephen J ^a,d   Vanella, Luca ^a,c   Gotlinger, Katherine ^a   Jiang, Houli ^a   Singh, Shailendra P ^a   Sodhi, Komal ^b   Maher, Eamonn ^b   O'Hanlon, Kathleen ^b   Shapiro, Joseph I ^b   Abraham, Nader G ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

^d NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

20 HETE; Adiponectin; Angiotensin ll; Female; Inflammation; Isoprostane; Obesity; OX HDL

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ADIPONECTIN; ANGIOTENSIN II; HEME OXYGENASE 1; HIGH DENSITY LIPOPROTEIN; ISOPROSTANE DERIVATIVE; OXIDIZED HIGH DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; ADIPOQ PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; HYDROXYICOSATETRAENOIC ACID; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR;

ADIPOCYTE; ADIPOGENESIS; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MEDICAL DOCUMENTATION; MEDICAL HISTORY; MESENCHYMAL STEM CELL; METABOLIC SYNDROME X; MIDDLE AGED; PHYSICAL EXAMINATION; YOUNG ADULT; AGONISTS; CASE CONTROL STUDY; COMPLICATION; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OBESITY; PATHOLOGY; PRIMARY CELL CULTURE;

ADIPOCYTES; ADIPOGENESIS; ADIPONECTIN; ADULT; ANGIOTENSIN II; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; F2-ISOPROSTANES; FEMALE; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LIPOPROTEINS, LDL; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PRIMARY CELL CULTURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84971260933     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2016.04.004     Document Type: Review

References (80)

1. Y. Hu, S.N. Bhupathiraju, K.L. De, and F.B. Hu Duration of obesity and overweight and risk of type 2 diabetes among us women Obesity (Silver Spring) 22 2014 2267 2273
2. J.E. Hall The kidney, hypertension, and obesity Hypertension 41 2003 625 633
3. M.E. Hall, G. Smith, J.E. Hall, and D.E. Stec Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity Am. J. Physiol. Regul. Integr. Comp. Physiol. 303 2012 R1241 R1250
4. M.D. Huffman, D.M. Lloyd-Jones, H. Ning, D.R. Labarthe, C.M. Guzman, M. O'flaherty, and et al. Quantifying options for reducing coronary heart disease mortality by 2020 Circulation 127 2013 2477 2484
5. C.M. Stalls, M.A. Triplette, A.J. Viera, D.E. Pathman, M.G. Cohen, and J.S. Rossi The association between body mass index and coronary artery disease severity: a comparison of black and white patients Am. Heart J. 167 2014 514 520
6. J.Q. Purnell, B. Zinman, and J.D. Brunzell The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study (Dcct/Edic) study Circulation 127 2013 180 187
7. C.L. Ogden, M.D. Carroll, B.K. Kit, and K.M. Flegal Prevalence of childhood and adult obesity in the United States, 2011-2012 JAMA 311 2014 806 814
8. K.M. Mctigue, Y.F. Chang, C. Eaton, L. Garcia, K.C. Johnson, C.E. Lewis, and et al. Severe obesity, heart disease, and death among White, African American, and Hispanic postmenopausal women Obesity (Silver Spring) 22 2014 801 810
9. C. Kaya, A.F. Erkan, S.D. Cengiz, I. Dunder, O.E. Demirel, and A. Bilgihan Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome Fertil. Steril. 92 2009 1372 1377
10. Y. Lin, A.H. Berg, P. Iyengar, T.K. Lam, A. Giacca, T.P. Combs, and et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species J. Biol. Chem. 280 2005 4617 4626
11. N.G. Abraham, T. Kushida, J. Mcclung, M. Weiss, S. Quan, R. Lafaro, and et al. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells Circ. Res. 93 2003 507 514
12. N.G. Abraham, R. Rezzani, L. Rodella, A. Kruger, D. Taller, V.G. Li, and et al. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes Am. J. Physiol. Heart Circ. Physiol. 287 2004 H2468 H2477
13. J.J. Chen, and I.M. London Hemin enhances the differentiation of mouse 3t3cells to adipocytes Cell 26 1981 117 122
14. N. Kumar, L.A. Solt, Y. Wang, P.M. Rogers, G. Bhattacharyya, T.M. Kamenecka, and et al. Regulation of adipogenesis by natural and synthetic Rev-Erb ligands Endocrinology 151 2010 3015 3025
15. N.G. Abraham, and A. Kappas Pharmacological and clinical aspects of heme oxygenase Pharmacol. Rev. 60 2008 79 127
16. N.G. Abraham, J.M. Junge, and G.S. Drummond Translational significance of heme oxygenase in obesity and metabolic syndrome Trends Pharmacol. Sci. October (26) 2015 (Pii: S0165-S6147)
17. L.A. Cassis, S.B. Police, F. Yiannikouris, and S.E. Thatcher Local adipose tissue renin-angiotensin system Curr. Hypertens. Rep. 10 2008 93 98
18. C.M. Boustany, K. Bharadwaj, A. Daugherty, D.R. Brown, D.C. Randall, and L.A. Cassis Activation of the systemic and adipose renin-angiotensin system In rats with diet-induced obesity and hypertension Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 2004 R943 R949
19. A.L. Kruger, S.J. Peterson, M.L. Schwartzman, H. Fusco, J.A. Mcclung, M. Weiss, and et al. Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects J. Pharmacol. Exp. Ther. 319 2006 1144 1152
20. R. Kinobe, Y. Ji, and K. Nakatsu Peroxynitrite-mediated inactivation of heme oxygenases BMC Pharmacol. 4 2004 26
21. T.D. Hinds Jr., K. Sodhi, C. Meadows, L. Fedorova, N. Puri, D.H. Kim, and et al. Increased Ho-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of Fgf21 Obesity (Silver Spring) 22 2014 705 712
22. F. Yiannikouris, Y. Wang, R. Shoemaker, N. Larian, J. Thompson, V.L. English, and et al. Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice Hypertension 66 2015 836 842
23. X. Guo, L. Zheng, Y. Li, S. Yu, X. Zhou, R. Wang, and et al. Gender-specific prevalence and associated risk factors of prehypertension among rural children and adolescents in Northeast China: a cross-sectional study Eur. J. Pediatr. 172 2013 223 230
24. F. Yiannikouris, M. Karounos, R. Charnigo, V.L. English, D.L. Rateri, A. Daugherty, and et al. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice Am. J. Physiol. Regul. Integr. Comp. Physiol. 302 2012 R244 R251
25. N.C. Ward, J. Rivera, J. Hodgson, I.B. Puddey, L.J. Beilin, J.R. Falck, and et al. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans Circulation 110 2004 438 443
26. I.J. Tsai, K.D. Croft, T.A. Mori, J.R. Falck, L.J. Beilin, I.B. Puddey, and et al. 20-Hete and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction Free Radic. Biol. Med. 46 2009 263 270
27. J.A. Saye, L.A. Cassis, T.W. Sturgill, K.R. Lynch, and M.J. Peach Angiotensinogen gene expression in 3t3-L1 cells Am. J. Physiol. 256 1989 C448 C451
28. L.A. Cassis, V.L. English, K. Bharadwaj, and C.M. Boustany Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes Endocrinology 145 2004 169 174
29. D.H. Kim, N. Puri, K. Sodhi, J.R. Falck, N.G. Abraham, J. Shapiro, and et al. Cyclooxygenase-2 dependent metabolism of 20-Hete increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes J. Lipid Res. 54 2013 786 793
30. J. Cheng, V. Garcia, Y. Ding, C.C. Wu, K. Thakar, J.R. Falck, and et al. Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction Arterioscler. Thromb. Vasc. Biol. 32 2012 1917 1924
31. K. Sodhi, C.C. Wu, J. Cheng, K. Gotlinger, K. Inoue, M. Goli, and et al. Cyp4a2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent Hypertension 56 2010 871 878
32. C.L. Laffer, M. Laniado-Schwartzman, M.H. Wang, A. Nasjletti, and F. Elijovich Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension Circulation 107 2003 574 578
33. C.L. Laffer, M. Laniado-Schwartzman, A. Nasjletti, and F. Elijovich 20-Hete and circulating insulin In essential hypertension with obesity Hypertension 43 2004 388 392
34. M.H. Gangadhariah, J.M. Luther, V. Garcia, P. Paueksakon, M.Z. Zhang, S.W. Hayward, and et al. Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy J. Am. Soc. Nephrol. 26 2015 597 610
35. A.P. Burgess, L. Vanella, L. Bellner, K. Gotlinger, J.R. Falck, N.G. Abraham, and et al. Heme oxygenase (Ho-1) rescue of adipocyte dysfunction in Ho-2 deficient mice via recruitment of epoxyeicosatrienoic acids (Eets) and adiponectin Cell. Physiol. Biochem. 29 2012 99 110
36. S. Munusamy, J.M. Do Carmo, J.P. Hosler, and J.E. Hall Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin Am. J. Physiol. Renal Physiol. 309 2015 F731 F743
37. V. Garcia, G. Joseph, B. Shkolnik, Y. Ding, F.F. Zhang, K. Gotlinger, and et al. Angiotensin II receptor blockade or deletion of vascular endothelial ace does not prevent vascular dysfunction and remodeling in 20-Hete-dependent hypertension Am. J. Physiol. Regul. Integr. Comp. Physiol. 309 2015 R71 R78
38. C.C. Wu, T. Gupta, V. Garcia, Y. Ding, and M.L. Schwartzman 20-Hete and blood pressure regulation: clinical implications Cardiol. Rev. 22 2014 1 12
39. S.J. Peterson, D.H. Kim, M. Li, V. Positano, L. Vanella, L.F. Rodella, and et al. The L-4f mimetic peptide prevents insulin resistance through increased levels of Ho-1, pampk, and pakt in obese mice J. Lipid Res. 50 2009 1293 1304
40. A. Burgess, M. Li, L. Vanella, D.H. Kim, R. Rezzani, L. Rodella, and et al. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice Hypertension 56 2010 1124 1130
41. T.F. Luscher, U. Landmesser, E.A. Von, and A.M. Fogelman High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target Circ. Res. 114 2014 171 182
42. N.G. Abraham Molecular regulation? Biological role of heme in hematopoiesis Blood Rev. 5 1991 19 28
43. J.D. Lutton, M.L. Schwartzman, and N.G. Abraham Cytochrome P450 dependent arachidonic acid metabolism in hemopoietic cells Adv. Exp. Med. Biol. 271 1989 115 121
44. J.D. Lutton, K. Solangi, J.Y. Ran, J.D. Cooper, A. Goodman, N.G. Abraham, and et al. Development of a cytochrome P-450 monooxygenase system in clonogenic hemopoietic cells Res. Commun. Chem. Pathol. Pharmacol. 56 1987 87 99
45. N.G. Abraham, E. Feldman, J.R. Falck, J.D. Lutton, and M.L. Schwartzman Modulation of erythropoiesis by novel human bone marrow cytochrome P450-dependent metabolites of arachidonic acid Blood 78 1991 1461 1466
46. B.M. Spiegelman, L. Choy, G.S. Hotamisligil, R.A. Graves, and P. Tontonoz Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes J. Biol. Chem. 268 1993 6823 6826
47. F.M. Gregoire, C.M. Smas, and H.S. Sul Understanding adipocyte differentiation Physiol. Rev. 78 1998 783 809
48. F.T. Lin, and M.D. Lane Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3t3-L1 preadipocytes Genes Dev. 6 1992 533 544
49. L. Vanella, M. Li, D. Kim, G. Malfa, L. Bellner, T. Kawakami, and et al. Apoa1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (Ho-1) and Wnt10b Cell Cycle 11 2012 706 714
50. L. Vanella, K. Sodhi, D.H. Kim, N. Puri, M. Maheshwari, T.D. Hinds Jr., and et al. Increased heme-oxygenase 1 expression decreases adipocyte differentiation and lipid accumulation in mesenchymal stem cells via upregulation of the canonical wnt signaling cascade Stem Cell Res. Ther. 4 2013 28
51. M. Takahashi, Y. Kamei, and O. Ezaki Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size Am. J. Physiol. Endocrinol. Metab. 288 2005 E117 E124
52. L. Vanella, D.H. Kim, K. Sodhi, I. Barbagallo, A.P. Burgess, J.R. Falck, and et al. Crosstalk between Eet and Ho-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes Prostaglandins Other Lipid Mediat. 96 2011 54 62
53. D.H. Kim, L. Vanella, K. Inoue, A. Burgess, K. Gotlinger, V.L. Manthati, and et al. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of Ho-1-Pakt signaling and a decrease in ppargamma Stem Cells Dev. 19 2010 1863 1873
54. N.G. Abraham, K. Sodhi, A.M. Silvis, L. Vanella, G. Favero, R. Rezzani, and et al. Cyp2j2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype Hypertension 64 2014 1352 1361
55. T. Lundasen, M.C. Hunt, L.M. Nilsson, S. Sanyal, B. Angelin, S.E. Alexson, and et al. Pparalpha is a key regulator of hepatic Fgf21 Biochem. Biophys. Res. Commun. 360 2007 437 440
56. R. Basu, U.B. Pajvani, R.A. Rizza, and P.E. Scherer Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects Diabetes 56 2007 2174 2177
57. A.H. Berg, and P.E. Scherer Adipose tissue, inflammation, and cardiovascular disease Circ. Res. 96 2005 939 949
58. L. Fontana, J.C. Eagon, M.E. Trujillo, P.E. Scherer, and S. Klein Visceral fat adipokine secretion is associated with systemic inflammation in obese humans Diabetes 56 2007 1010 1013
59. N. Halberg, T.D. Schraw, Z.V. Wang, J.Y. Kim, J. Yi, M.P. Hamilton, and et al. Systemic fate of the adipocyte-derived factor adiponectin Diabetes 58 2009 1961 1970
60. J.Y. Kim, W.E. Van De, M. Laplante, A. Azzara, M.E. Trujillo, S.M. Hofmann, and et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue J. Clin. Invest. 117 2007 2621 2637
61. B. Pan, B. Yu, H. Ren, B. Willard, L. Pan, L. Zu, and et al. High-density lipoprotein nitration and chlorination catalyzed by myeloperoxidase impair its effect of promoting endothelial repair Free Radic. Biol. Med. 60 2013 272 281
62. J.M. Proudfoot, A.E. Barden, W.M. Loke, K.D. Croft, I.B. Puddey, and T.A. Mori Hdl is the major lipoprotein carrier of plasma F2-isoprostanes J. Lipid Res. 50 2009 716 722
63. S.J. Nicholls, L. Zheng, and S.L. Hazen Formation of dysfunctional high-density lipoprotein by myeloperoxidase Trends Cardiovasc. Med. 15 2005 212 219
64. M.J. Puchades, G. Saez, M.C. Munoz, M. Gonzalez, I. Torregrosa, I. Juan, and et al. Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis Clin. Nephrol. 80 2013 177 186
65. P. Montuschi, P.J. Barnes, and L.J. Roberts Isoprostanes: markers and mediators of oxidative stress FASEB J. 18 2004 1791 1800
66. P. Montuschi, P. Barnes, and L.J. Roberts Insights into oxidative stress: the isoprostanes Curr. Med. Chem. 14 2007 703 717
67. M. Navab, S.T. Reddy, B.J. Van Lenten, G.M. Anantharamaiah, and A.M. Fogelman The role of dysfunctional Hdl in atherosclerosis J. Lipid Res. 50 Suppl 2009 S145 S149
68. B.J. Ansell, G.C. Fonarow, and A.M. Fogelman The paradox of dysfunctional high-density lipoprotein Curr. Opin. Lipidol. 18 2007 427 434
69. J.B. Kim, S. Hama, G. Hough, M. Navab, A.M. Fogelman, W.R. Maclellan, and et al. Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins Am. J. Cardiol. 112 2013 1770 1777
70. S. Imaizumi, M. Navab, C. Morgantini, C. Charles-Schoeman, F. Su, F. Gao, and et al. Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins Circ. J. 75 2011 1533 1538
71. B.J. Ansell, G.C. Fonarow, M. Navab, and A.M. Fogelman Modifying the anti-Inflammatory effects of high-density lipoprotein Curr. Atheroscler. Rep. 9 2007 57 63
72. M. Navab, S.Y. Hama, S.T. Reddy, C.J. Ng, B.J. Van Lenten, H. Laks, and et al. Oxidized lipids as mediators of coronary heart disease Curr. Opin. Lipidol. 13 2002 363 372
73. K. Nishi, H. Itabe, M. Uno, K.T. Kitazato, H. Horiguchi, K. Shinno, and et al. Oxidized Ldl in carotid plaques and plasma associates with plaque instability Arterioscler. Thromb. Vasc. Biol. 22 2002 1649 1654
74. S. Ehara, M. Ueda, T. Naruko, K. Haze, A. Itoh, M. Otsuka, and et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 2001 1955 1960
75. P. Holvoet, J. Vanhaecke, S. Janssens, F. Van De Werf, and D. Collen Oxidized Ldl and malondialdehyde-modified Ldl in patients with acute coronary syndromes and stable coronary artery disease Circulation 98 1998 1487 1494
76. T. Vasankari, M. Ahotupa, J. Toikka, J. Mikkola, K. Irjala, P. Pasanen, and et al. Oxidized ldl and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized Ldl with statin therapy Atherosclerosis 155 2001 403 412
77. B. Shao Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by Abca1, a key cardioprotective function of Hdl Biochim. Biophys. Acta 1821 2012 490 501
78. M. Anselmi, U. Garbin, P. Agostoni, M. Fusaro, A.F. Pasini, C. Nava, and et al. Plasma levels of oxidized-low-density lipoproteins are higher In patients with unstable angina and correlated with angiographic coronary complex plaques Atherosclerosis 185 2006 114 120
79. Z. Khitan, M. Harsh, K. Sodhi, J.I. Shapiro, and N.G. Abraham Ho-1 upregulation attenuates adipocyte dysfunction, obesity, and isoprostane levels in mice fed high fructose diets J. Nutr. Metab. 2014 2014 980547
80. J. Cao, S.J. Peterson, K. Sodhi, L. Vanella, I. Barbagallo, L.F. Rodella, and et al. Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet Hypertension 60 2012 467 475